Pacer International Export Leaders ETF

US FDA Approves AstraZeneca's Oral Treatment Regimen for CLL and SLL

AstraZeneca's Fixed-duration Calquence Combination Therapy Approved in the US

Ontario Teachers' Pension Plan Sells Down AstraZeneca Shares

BHP Group Limited released FY2026 Q1 earnings on February 16, 2026 (EST), with actual revenue of USD 13.95 B and EPS of USD 0.554

BHP Group Limited released FY2026 Q2 earnings on February 16 Pre-Market EST, with actual revenue of USD 13.95 B and EPS of USD 0.554

BHP Group Limited released FY2026 Semi-Annual earnings on February 16 Pre-Market (EST), actual revenue USD 27.9 B (forecast USD 27.43 B), actual EPS USD 1.108

Deutsche Bank Analyst Maintains Sell Rating on AstraZeneca

Genentech's Gazyva Phase III Study for Primary Membranous Nephropathy Successful

Bernstein Raises Astrazeneca Target Price to 20,500 Pence

AstraZeneca Reports Positive Results from Breztri Aerosphere Phase III Clinical Trials

AstraZeneca's China R&D Team Transforms into Global Decision Maker

AstraZeneca released FY2025 earnings on February 10 Pre-Market (EST), actual revenue USD 58.74 B (forecast USD 58.65 B), actual EPS USD 6.54 (forecast USD 3.633)

AstraZeneca released FY2025 Q4 earnings on February 10 Pre-Market (EST), actual revenue USD 15.5 B (forecast USD 15.37 B), actual EPS USD 1.49 (forecast USD 1.1053)

AstraZeneca's Durvalumab Receives NICE Support for Muscle-Invasive Bladder Cancer Treatment

AstraZeneca May Shift to a More Restricted Rebate Model

AstraZeneca CEO Praises US-UK Drug Price Agreement But Finds It Inadequate

AstraZeneca Anticipates Mid-to-High-Single-Digit Growth in Full-Year Revenue

AstraZeneca Q4 Earnings Fall Short of Market Expectations with $2.12 EPS

AstraZeneca Predicts Revenue Growth and Acquires CSPC Pharmaceuticals' Drug Rights

BHP Group Limited to release FY2026 Semi-Annual earnings on February 16, 2026 (EST), forecast revenue USD 27.39 B

Tian Ruixiang

Arcellx

Allurion Tech

Signing Day Sports

Vanda Pharma

J-Star

Klotho Neurosciences

Reliance Global

Jyong Biotech

Genprex

PIEL

SMDS

<p>International Paperannounced plans to split into two publicly traded companies by spinning off its European packaging business. Shares rose about 5% in premarket trading. The company, which holds a significant share of the North American corrugated packaging market, has been divesting assets in Europe following its $7.22 billion acquisition of DS Smith. The separation is expected to be completed in 12-15 months amid slowing demand for box shipments due to cautious consumer spending and trade uncertainties.</p>

Reuters

International Paper

DS Smith Plc

Packaging firm International Paper to split into two companies

WOOD

<p>International Paper has finalized the sale of its Global Cellulose Fibers business to American Industrial Partners for $1.5 billion. This transaction includes preferred stock valued at $190 million. The GCF business, which generated approximately $2.3 billion in revenue in 2024, produces high-quality pulp for various personal care products and sustainable materials. International Paper, headquartered in Memphis, employs over 65,000 people globally and reported net sales of $18.6 billion in 2024.</p>

StockTitan

Guggenheim MSCI Global Timber

iShares S&P Global Timber Forestry

International Paper Completes Sale of Global Cellulose Fibers Business to American Industrial Partners (AIP) | IP Stock News

Pacer International Export Leaders ETF(PIEL.US)

Packaging firm International Paper to split into two companies

International Paper Completes Sale of Global Cellulose Fibers Business to American Industrial Partners (AIP) | IP Stock News